CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Engmab's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
Aug 16, 2023Bispecific Antibodies Against Cd3Epsilon And Bcma For Use In Treatment Of Diseases3

Top competitors of Engmab

Top competitors of Engmab based on patent oppositions.